Companies attract venture funding for redesigned psychedelic drugs

CSO Jesper L. Kristensen comments on the advantageous position of LPH-5 in the landscape of next generation psychedelics.

https://www.scientificamerican.com/article/should-next-generation-psychedelics-skip-the-trip